AXS Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.2K Sell
367
-30
-8% -$6.99K 0.03% 140
2026
Q1
$97K Sell
397
-117
-23% -$27.3K 0.04% 135
2025
Q4
$106K Sell
514
-157
-23% -$31K 0.04% 143
2025
Q3
$124K Buy
+671
New +$115K 0.04% 144
2024
Q4
– Sell
-8,672
Closed -$1.41M – 232
2024
Q3
$1.41M Sell
8,672
-418
-5% -$66.6K 0.37% 119
2024
Q2
$1.33M Buy
9,090
+402
+5% +$59.8K 0.37% 97
2024
Q1
$1.37M Sell
8,688
-425
-5% -$67.6K 0.33% 100
2023
Q4
$1.43M Buy
9,113
+251
+3% +$38.5K 0.34% 94
2023
Q3
$1.38M Sell
8,862
-313
-3% -$51.6K 0.36% 76
2023
Q2
$1.52M Sell
9,175
-200
-2% -$32.3K 0.41% 64
2023
Q1
$1.45M Buy
9,375
+1,334
+17% +$215K 0.48% 50
2022
Q4
$1.42M Sell
8,041
-164
-2% -$28.3K 0.51% 50
2022
Q3
$1.34M Hold
8,205
– – 0.52% 46
2022
Q2
$1.46M Buy
8,205
+4,622
+129% +$824K 0.52% 41
2022
Q1
$635K Sell
3,583
-4,122
-53% -$701K 0.25% 73
2021
Q4
$1.32M Buy
7,705
+5,881
+322% +$963K 0.31% 67
2021
Q3
$295K Sell
1,824
-5,080
-74% -$867K 0.11% 82
2021
Q2
$1.14M Buy
6,904
+1,671
+32% +$277K 0.35% 71
2021
Q1
$860K Buy
+5,233
New +$847K 0.31% 80

Other funds holding JNJ

AXS Investments's JNJ Position: Q2 2026 in Review

AXS Investments reduced its Johnson & Johnson (JNJ) stake by 7.6% in Q2 2026, selling an estimated $6.99K and leaving 367 shares worth $93.2K. The position accounts for 0.03% of the portfolio, ranked #140.

AXS Investments first reported a position in JNJ in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.52M in Q2 2023. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AXS Investments held 367 shares of Johnson & Johnson worth $93.2K as of Q2 2026.
  • AXS Investments sold 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
  • Johnson & Johnson made up 0.03% of AXS Investments's portfolio in Q2 2026, its #140 holding.
  • AXS Investments first reported a position in Johnson & Johnson in Q1 2021 and has held it in 19 quarters since.
  • AXS Investments's Johnson & Johnson position peaked at $1.52M in Q2 2023.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.